Annual report pursuant to Section 13 and 15(d)

NET LOSS PER SHARE

v2.4.0.8
NET LOSS PER SHARE
12 Months Ended
Mar. 31, 2014
NET LOSS PER SHARE [Abstract]  
NET LOSS PER SHARE

NOTE 13: NET LOSS PER SHARE

Equity Instruments Outstanding

We have stock options and restricted stock units granted under various stock incentive plans that, upon exercise and vesting, respectively, would increase shares outstanding. We have 4.50% convertible subordinated notes which are convertible at the option of the holders at any time prior to maturity into shares of Quantum common stock at a conversion price of $1.65 per share. We also have 3.50% convertible subordinated notes which are convertible at the option of the holders at any time prior to maturity into shares of Quantum common stock at a conversion price of $4.33 per share. Both the 4.50% and the 3.50% notes, if converted, would increase shares outstanding.

On June 23, 2009, we issued a warrant to EMC Corporation to purchase 10 million shares of our common stock at a $0.38 per share exercise price. Only in the event of a change of control of Quantum will this warrant vest and be exercisable. The warrant expires seven years from the date of issuance or three years after change of control, whichever occurs first. Due to these terms, no share-based compensation expense related to this warrant has been recorded to date.

Net Loss per Share

The following table set forth the computation of basic and diluted net loss per share (in thousands, except per-share data):

  For the year ended March 31,
  2014       2013       2012
Net loss $       (21,474 )   $       (52,179 )   $       (9,256 )
Weighted average shares:                      
       Basic and diluted   247,024       239,855       232,599  
Basic and diluted net loss per share $ (0.09 )   $ (0.22 )   $ (0.04 )

The computations of diluted net loss per share for the periods presented excluded the following because the effect would have been antidilutive:

  • For fiscal 2014, 2013 and 2012, there were 31.1 million, 31.2 million and 31.2 million, respectively, of weighted equivalent shares of the 3.50% convertible subordinated notes, were excluded. In addition, 42.5 million and 17.6 million weighted equivalent shares of the 4.50% notes for fiscal 2014 and 2013, respectively, were excluded.
  • Stock options to purchase 12.8 million, 17.3 million and 11.5 million weighted average shares in fiscal 2014, 2013 and 2012, respectively, were excluded.
  • Unvested restricted stock units of 11.0 million, 10.1 million, and 5.1 million weighted average shares for fiscal 2014, 2013 and 2012, respectively, were excluded.